HC
NVO

Hurley Capital’s Novo Nordisk NVO Stock Holding History

Hurley Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$221 Buy
+6
New +$284 ﹤0.01% 638
2025
Q3 		– Sell
-160
Closed -$11K – 697
2025
Q2 		$11K Hold
160
– – 0.01% 299
2025
Q1 		$11.1K Hold
160
– – 0.01% 312
2024
Q4 		$14K Buy
+160
New +$17.3K 0.01% 254

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Hurley Capital's NVO Position: Q1 2026 in Review

Hurley Capital opened a new position in Novo Nordisk (NVO) in Q1 2026: 6 shares worth $221. The stake represents ﹤0.01% of the portfolio and ranks #638 among its holdings. This is a return to the name: Hurley Capital previously reported a position in NVO as recently as Q2 2025.

Hurley Capital first reported a position in NVO in Q4 2024 and has held it in 4 quarters since. The position peaked at $14K in Q4 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Hurley Capital held 6 shares of Novo Nordisk worth $221 as of Q1 2026.
  • Novo Nordisk was a new Hurley Capital position in Q1 2026.
  • Novo Nordisk made up ﹤0.01% of Hurley Capital's portfolio in Q1 2026, its #638 holding.
  • Hurley Capital first reported a position in Novo Nordisk in Q4 2024 and has held it in 4 quarters since.
  • Hurley Capital's Novo Nordisk position peaked at $14K in Q4 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.